Kellanova (K) reported $3.12 billion in revenue for the quarter ended December 2024, representing a year-over-year decline of 1.6%. EPS of $0.92 for the same period compares to $0.78 a year ago.

The reported revenue represents a surprise of +1.00% over the Zacks Consensus Estimate of $3.09 billion. With the consensus EPS estimate being $0.82, the EPS surprise was +12.20%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Kellanova performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Net sales - AMEA - Forex impact - YoY change: -34.3% versus the three-analyst average estimate of -28.9%.
• Total Reported growth: -1.6% versus -2.6% estimated by three analysts on average.
• Net sales - Consolidated - price / mix impact - YoY change: 4.2% compared to the 4.8% average estimate based on three analysts.
• Net sales - North America - Volume impact - YoY change: 0.5% versus 0.2% estimated by three analysts on average.
• Net sales - North America - Price / mix impact - YoY change: -2% versus the three-analyst average estimate of 0.7%.
• Net sales - North America - Forex impact - YoY change: -0.2% versus the three-analyst average estimate of -0.1%.
• Net sales - Europe - Price / mix impact - YoY change: 2% versus the three-analyst average estimate of 3.3%.
• Net sales - Europe - Forex impact - YoY change: -0.8% versus the three-analyst average estimate of 1.4%.
• Net sales- Latin America: $303 million versus the three-analyst average estimate of $304.79 million. The reported number represents a year-over-year change of -7.6%.
• Net sales- Europe: $601 million versus $641.84 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -2% change.
• Net sales- North America: $1.56 billion versus the three-analyst average estimate of $1.60 billion. The reported number represents a year-over-year change of -1.7%.
• Net sales- AMEA: $659 million compared to the $546.24 million average estimate based on three analysts. The reported number represents a change of +2.2% year over year.

View all Key Company Metrics for Kellanova here>>>

Shares of Kellanova have returned +0.4% over the past month versus the Zacks S&P 500 composite's +2.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Kellanova (K) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research